SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-17-000225
Filing Date
2017-01-26
Accepted
2017-01-26 14:38:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 KITE_PHARMA_INC.HTM SC 13G 40931
  Complete submission text file 0000019617-17-000225.txt   42723
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

IRS No.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks

Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Subject) CIK: 0001510580 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-88615 | Film No.: 17549271
SIC: 2836 Biological Products, (No Diagnostic Substances)